Comment on "Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study".
Dear Editor, Gautam et al. [1], followed hundred and eleven statin-naive patients after coronary syndrome. Only half of these patients reached an LDL-C lower than milligrams per deciliter after twenty-eight days of high-intensity statin therapy. Tracking LDL-C levels with measurements during the first month is useful. The suggestion to initiate combination therapy earlier is reasonable. However, several numbers reported by the authors do not match. The reported percentage changes for lipids se...